(TheNewswire)
Vancouver, British Columbia / TheNewswire / September 18, 2017 – AREV Nutrition Sciences Inc. (" AREV " or the “Company”) (
CNSX - ARV ), is pleased to announce that Guy Dancosse has joined the team as a director of AREV
effective September 18, 2017.
Guy P. Dancosse, Q.C., icd.D, CIRC has extensive experience in arbitration, negotiation and mediation,
nationally and internationally, in many areas of business and the public sector. He has pleaded at all levels of the provincial and
federal courts in Canada, including the Supreme Court of Canada. He acted as counsel in commercial arbitration, both nationally and
internationally. He also acted as an arbitrator in commercial cases (I.C.C. / C.P.R. (ad hoc)).
He was part of Canadian Task Forces and Inquiry Commissions (Pilotage and Native Land Claims) and headed World
Bank missions in Africa (Tanzania, Chad). In Tanzania, Mr. Dancosse reviewed and recommended reforms to the country’s legal sector.
In Chad, he advised government officials on air transport issues.
He has undergone post-graduate training in mediation and arbitration at Harvard University (Boston),
successfully completed the Director’s Education Program at Rotman School of Business in Toronto (University of Toronto), and is a
member of the Board of Directors and Chair of the Human Resources Committee at the Royal Canadian Mint. He is also a member of the
Board of Directors of Fronsac inc. (a commercial real estate REIT), where he is part of the Governance Committee.
He is a certified member of the Institute of Corporate Directors and is accredited as an international
commercial arbitrator by the ICC (International Chamber of Commerce, Paris – ICC Canada).
“Guy is a great addition to the Board” said Stephane Maher, CEO. “He will bring extensive business
experience, valuable knowledge of the current landscape in the cannabis industry, and further enhance our corporate
governance. His extensive network and relationships across Canada and the U.S. will help AREV in the execution of our strategy to
develop solid partnerships within the cannabis industry”.
The Company, effective immediately, has issued Mr. Dancosse 100,000 stock options as a signing bonus for
agreeing to be a part of the team at AREV and put in place a milestone bonus of 200,000 common shares of the Company for signing a
definitive agreement (or the like) with strategic alliances that are currently under discussion.
For further information, contact Stephane Maher, CEO at stephane@arevnutrition.com.
On behalf of the Board,
Stephane Maher
Chief Executive Officer & Director
About AREV Nutrition Sciences Inc.
AREV Nutrition Sciences Inc. (“AREV”), produces and delivers functional ingredients from its world-class
extraction system. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through
emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food,
nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an
innovative emulsified base formula to disperse Cannabis oil extracts.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR
ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in
policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include
forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical
fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking
statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or
developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ
materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued
availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such
statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not
assume any obligation to update any forward-looking statements except as required under the applicable laws.This press release
contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will",
"project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the
Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue
reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to
be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks
and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from
those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s
Discussion and Analysis under the Company’s profile on www.sedar.com.
Copyright (c) 2017 TheNewswire - All rights reserved.